Global Parkinson's Disease Treatments Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Parkinson's Disease Treatments Market Size 2017-2028

2.1.2 Parkinson's Disease Treatments Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Parkinson's Disease Treatments Segment by Type

2.2.1 Dopamine Agonists

2.2.2 Levodopa

2.2.3 Glutamate Antagonist

2.2.4 Apomorphine

2.2.5 COMT Inhibitors Anticholinergics

2.2.6 MAO-B Inhibitors

2.2.7 Other Drugs

2.3 Parkinson's Disease Treatments Market Size by Type

2.3.1 Parkinson's Disease Treatments Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Parkinson's Disease Treatments Market Size Market Share by Type (2017-2022)

2.4 Parkinson's Disease Treatments Segment by Application

2.4.1 Hospitals

2.4.2 Healthcare Institutes

2.4.3 Others

2.5 Parkinson's Disease Treatments Market Size by Application

2.5.1 Parkinson's Disease Treatments Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Parkinson's Disease Treatments Market Size Market Share by Application (2017-2022)

3 Parkinson's Disease Treatments Market Size by Player

3.1 Parkinson's Disease Treatments Market Size Market Share by Players

3.1.1 Global Parkinson's Disease Treatments Revenue by Players (2020-2022)

3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2020-2022)

3.2 Global Parkinson's Disease Treatments Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Parkinson's Disease Treatments by Regions

4.1 Parkinson's Disease Treatments Market Size by Regions (2017-2022)

4.2 Americas Parkinson's Disease Treatments Market Size Growth (2017-2022)

4.3 APAC Parkinson's Disease Treatments Market Size Growth (2017-2022)

4.4 Europe Parkinson's Disease Treatments Market Size Growth (2017-2022)

4.5 Middle East & Africa Parkinson's Disease Treatments Market Size Growth (2017-2022)

5 Americas

5.1 Americas Parkinson's Disease Treatments Market Size by Country (2017-2022)

5.2 Americas Parkinson's Disease Treatments Market Size by Type (2017-2022)

5.3 Americas Parkinson's Disease Treatments Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Parkinson's Disease Treatments Market Size by Region (2017-2022)

6.2 APAC Parkinson's Disease Treatments Market Size by Type (2017-2022)

6.3 APAC Parkinson's Disease Treatments Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Parkinson's Disease Treatments by Country (2017-2022)

7.2 Europe Parkinson's Disease Treatments Market Size by Type (2017-2022)

7.3 Europe Parkinson's Disease Treatments Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Parkinson's Disease Treatments by Region (2017-2022)

8.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2017-2022)

8.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Parkinson's Disease Treatments Market Forecast

10.1 Global Parkinson's Disease Treatments Forecast by Regions (2023-2028)

10.1.1 Global Parkinson's Disease Treatments Forecast by Regions (2023-2028)

10.1.2 Americas Parkinson's Disease Treatments Forecast

10.1.3 APAC Parkinson's Disease Treatments Forecast

10.1.4 Europe Parkinson's Disease Treatments Forecast

10.1.5 Middle East & Africa Parkinson's Disease Treatments Forecast

10.2 Americas Parkinson's Disease Treatments Forecast by Country (2023-2028)

10.2.1 United States Parkinson's Disease Treatments Market Forecast

10.2.2 Canada Parkinson's Disease Treatments Market Forecast

10.2.3 Mexico Parkinson's Disease Treatments Market Forecast

10.2.4 Brazil Parkinson's Disease Treatments Market Forecast

10.3 APAC Parkinson's Disease Treatments Forecast by Region (2023-2028)

10.3.1 China Parkinson's Disease Treatments Market Forecast

10.3.2 Japan Parkinson's Disease Treatments Market Forecast

10.3.3 Korea Parkinson's Disease Treatments Market Forecast

10.3.4 Southeast Asia Parkinson's Disease Treatments Market Forecast

10.3.5 India Parkinson's Disease Treatments Market Forecast

10.3.6 Australia Parkinson's Disease Treatments Market Forecast

10.4 Europe Parkinson's Disease Treatments Forecast by Country (2023-2028)

10.4.1 Germany Parkinson's Disease Treatments Market Forecast

10.4.2 France Parkinson's Disease Treatments Market Forecast

10.4.3 UK Parkinson's Disease Treatments Market Forecast

10.4.4 Italy Parkinson's Disease Treatments Market Forecast

10.4.5 Russia Parkinson's Disease Treatments Market Forecast

10.5 Middle East & Africa Parkinson's Disease Treatments Forecast by Region (2023-2028)

10.5.1 Egypt Parkinson's Disease Treatments Market Forecast

10.5.2 South Africa Parkinson's Disease Treatments Market Forecast

10.5.3 Israel Parkinson's Disease Treatments Market Forecast

10.5.4 Turkey Parkinson's Disease Treatments Market Forecast

10.5.5 GCC Countries Parkinson's Disease Treatments Market Forecast

10.6 Global Parkinson's Disease Treatments Forecast by Type (2023-2028)

10.7 Global Parkinson's Disease Treatments Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GSK

11.1.1 GSK Company Information

11.1.2 GSK Parkinson's Disease Treatments Product Offered

11.1.3 GSK Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GSK Main Business Overview

11.1.5 GSK Latest Developments

11.2 Merck

11.2.1 Merck Company Information

11.2.2 Merck Parkinson's Disease Treatments Product Offered

11.2.3 Merck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Merck Main Business Overview

11.2.5 Merck Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Parkinson's Disease Treatments Product Offered

11.3.3 Novartis Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Teva

11.4.1 Teva Company Information

11.4.2 Teva Parkinson's Disease Treatments Product Offered

11.4.3 Teva Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Teva Main Business Overview

11.4.5 Teva Latest Developments

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Information

11.5.2 Boehringer Ingelheim Parkinson's Disease Treatments Product Offered

11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Boehringer Ingelheim Main Business Overview

11.5.5 Boehringer Ingelheim Latest Developments

11.6 Impax

11.6.1 Impax Company Information

11.6.2 Impax Parkinson's Disease Treatments Product Offered

11.6.3 Impax Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Impax Main Business Overview

11.6.5 Impax Latest Developments

11.7 Abbvie

11.7.1 Abbvie Company Information

11.7.2 Abbvie Parkinson's Disease Treatments Product Offered

11.7.3 Abbvie Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Abbvie Main Business Overview

11.7.5 Abbvie Latest Developments

11.8 Bausch Health

11.8.1 Bausch Health Company Information

11.8.2 Bausch Health Parkinson's Disease Treatments Product Offered

11.8.3 Bausch Health Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Bausch Health Main Business Overview

11.8.5 Bausch Health Latest Developments

11.9 Lundbeck

11.9.1 Lundbeck Company Information

11.9.2 Lundbeck Parkinson's Disease Treatments Product Offered

11.9.3 Lundbeck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Lundbeck Main Business Overview

11.9.5 Lundbeck Latest Developments

11.10 Sun Pharma

11.10.1 Sun Pharma Company Information

11.10.2 Sun Pharma Parkinson's Disease Treatments Product Offered

11.10.3 Sun Pharma Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Sun Pharma Main Business Overview

11.10.5 Sun Pharma Latest Developments

11.11 Wockhardt

11.11.1 Wockhardt Company Information

11.11.2 Wockhardt Parkinson's Disease Treatments Product Offered

11.11.3 Wockhardt Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Wockhardt Main Business Overview

11.11.5 Wockhardt Latest Developments

11.12 Acadia

11.12.1 Acadia Company Information

11.12.2 Acadia Parkinson's Disease Treatments Product Offered

11.12.3 Acadia Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Acadia Main Business Overview

11.12.5 Acadia Latest Developments

11.13 UCB

11.13.1 UCB Company Information

11.13.2 UCB Parkinson's Disease Treatments Product Offered

11.13.3 UCB Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 UCB Main Business Overview

11.13.5 UCB Latest Developments

12 Research Findings and Conclusion

Table 1. Parkinson's Disease Treatments Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Dopamine Agonists

Table 3. Major Players of Levodopa

Table 4. Major Players of Glutamate Antagonist

Table 5. Major Players of Apomorphine

Table 6. Major Players of COMT Inhibitors Anticholinergics

Table 7. Major Players of MAO-B Inhibitors

Table 8. Major Players of Other Drugs

Table 9. Parkinson's Disease Treatments Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Parkinson's Disease Treatments Market Size by Type (2017-2022) & ($ Millions)

Table 11. Global Parkinson's Disease Treatments Market Size Market Share by Type (2017-2022)

Table 12. Parkinson's Disease Treatments Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Parkinson's Disease Treatments Market Size by Application (2017-2022) & ($ Millions)

Table 14. Global Parkinson's Disease Treatments Market Size Market Share by Application (2017-2022)

Table 15. Global Parkinson's Disease Treatments Revenue by Players (2020-2022) & ($ Millions)

Table 16. Global Parkinson's Disease Treatments Revenue Market Share by Player (2020-2022)

Table 17. Parkinson's Disease Treatments Key Players Head office and Products Offered

Table 18. Parkinson's Disease Treatments Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Parkinson's Disease Treatments Market Size by Regions 2017-2022 & ($ Millions)

Table 22. Global Parkinson's Disease Treatments Market Size Market Share by Regions (2017-2022)

Table 23. Americas Parkinson's Disease Treatments Market Size by Country (2017-2022) & ($ Millions)

Table 24. Americas Parkinson's Disease Treatments Market Size Market Share by Country (2017-2022)

Table 25. Americas Parkinson's Disease Treatments Market Size by Type (2017-2022) & ($ Millions)

Table 26. Americas Parkinson's Disease Treatments Market Size Market Share by Type (2017-2022)

Table 27. Americas Parkinson's Disease Treatments Market Size by Application (2017-2022) & ($ Millions)

Table 28. Americas Parkinson's Disease Treatments Market Size Market Share by Application (2017-2022)

Table 29. APAC Parkinson's Disease Treatments Market Size by Region (2017-2022) & ($ Millions)

Table 30. APAC Parkinson's Disease Treatments Market Size Market Share by Region (2017-2022)

Table 31. APAC Parkinson's Disease Treatments Market Size by Type (2017-2022) & ($ Millions)

Table 32. APAC Parkinson's Disease Treatments Market Size Market Share by Type (2017-2022)

Table 33. APAC Parkinson's Disease Treatments Market Size by Application (2017-2022) & ($ Millions)

Table 34. APAC Parkinson's Disease Treatments Market Size Market Share by Application (2017-2022)

Table 35. Europe Parkinson's Disease Treatments Market Size by Country (2017-2022) & ($ Millions)

Table 36. Europe Parkinson's Disease Treatments Market Size Market Share by Country (2017-2022)

Table 37. Europe Parkinson's Disease Treatments Market Size by Type (2017-2022) & ($ Millions)

Table 38. Europe Parkinson's Disease Treatments Market Size Market Share by Type (2017-2022)

Table 39. Europe Parkinson's Disease Treatments Market Size by Application (2017-2022) & ($ Millions)

Table 40. Europe Parkinson's Disease Treatments Market Size Market Share by Application (2017-2022)

Table 41. Middle East & Africa Parkinson's Disease Treatments Market Size by Region (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Region (2017-2022)

Table 43. Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Type (2017-2022)

Table 45. Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Application (2017-2022)

Table 47. Key Market Drivers & Growth Opportunities of Parkinson's Disease Treatments

Table 48. Key Market Challenges & Risks of Parkinson's Disease Treatments

Table 49. Key Industry Trends of Parkinson's Disease Treatments

Table 50. Global Parkinson's Disease Treatments Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 51. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Regions (2023-2028)

Table 52. Global Parkinson's Disease Treatments Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 53. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Type (2023-2028)

Table 54. Global Parkinson's Disease Treatments Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 55. Global Parkinson's Disease Treatments Market Size Market Share Forecast by Application (2023-2028)

Table 56. GSK Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 57. GSK Parkinson's Disease Treatments Product Offered

Table 58. GSK Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 59. GSK Main Business

Table 60. GSK Latest Developments

Table 61. Merck Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 62. Merck Parkinson's Disease Treatments Product Offered

Table 63. Merck Main Business

Table 64. Merck Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Merck Latest Developments

Table 66. Novartis Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 67. Novartis Parkinson's Disease Treatments Product Offered

Table 68. Novartis Main Business

Table 69. Novartis Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Novartis Latest Developments

Table 71. Teva Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 72. Teva Parkinson's Disease Treatments Product Offered

Table 73. Teva Main Business

Table 74. Teva Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Teva Latest Developments

Table 76. Boehringer Ingelheim Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 77. Boehringer Ingelheim Parkinson's Disease Treatments Product Offered

Table 78. Boehringer Ingelheim Main Business

Table 79. Boehringer Ingelheim Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Boehringer Ingelheim Latest Developments

Table 81. Impax Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 82. Impax Parkinson's Disease Treatments Product Offered

Table 83. Impax Main Business

Table 84. Impax Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Impax Latest Developments

Table 86. Abbvie Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 87. Abbvie Parkinson's Disease Treatments Product Offered

Table 88. Abbvie Main Business

Table 89. Abbvie Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Abbvie Latest Developments

Table 91. Bausch Health Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 92. Bausch Health Parkinson's Disease Treatments Product Offered

Table 93. Bausch Health Main Business

Table 94. Bausch Health Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Bausch Health Latest Developments

Table 96. Lundbeck Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 97. Lundbeck Parkinson's Disease Treatments Product Offered

Table 98. Lundbeck Main Business

Table 99. Lundbeck Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Lundbeck Latest Developments

Table 101. Sun Pharma Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 102. Sun Pharma Parkinson's Disease Treatments Product Offered

Table 103. Sun Pharma Main Business

Table 104. Sun Pharma Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Sun Pharma Latest Developments

Table 106. Wockhardt Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 107. Wockhardt Parkinson's Disease Treatments Product Offered

Table 108. Wockhardt Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 109. Wockhardt Main Business

Table 110. Wockhardt Latest Developments

Table 111. Acadia Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 112. Acadia Parkinson's Disease Treatments Product Offered

Table 113. Acadia Main Business

Table 114. Acadia Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Acadia Latest Developments

Table 116. UCB Details, Company Type, Parkinson's Disease Treatments Area Served and Its Competitors

Table 117. UCB Parkinson's Disease Treatments Product Offered

Table 118. UCB Main Business

Table 119. UCB Parkinson's Disease Treatments Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. UCB Latest Developments

List of Figures

Figure 1. Parkinson's Disease Treatments Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Parkinson's Disease Treatments Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Parkinson's Disease Treatments Market Size Market Share by Type in 2021

Figure 7. Parkinson's Disease Treatments in Hospitals

Figure 8. Global Parkinson's Disease Treatments Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Parkinson's Disease Treatments in Healthcare Institutes

Figure 10. Global Parkinson's Disease Treatments Market: Healthcare Institutes (2017-2022) & ($ Millions)

Figure 11. Parkinson's Disease Treatments in Others

Figure 12. Global Parkinson's Disease Treatments Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Parkinson's Disease Treatments Market Size Market Share by Application in 2021

Figure 14. Global Parkinson's Disease Treatments Revenue Market Share by Player in 2021

Figure 15. Global Parkinson's Disease Treatments Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Parkinson's Disease Treatments Market Size 2017-2022 ($ Millions)

Figure 17. APAC Parkinson's Disease Treatments Market Size 2017-2022 ($ Millions)

Figure 18. Europe Parkinson's Disease Treatments Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Parkinson's Disease Treatments Market Size 2017-2022 ($ Millions)

Figure 20. Americas Parkinson's Disease Treatments Value Market Share by Country in 2021

Figure 21. Americas Parkinson's Disease Treatments Consumption Market Share by Type in 2021

Figure 22. Americas Parkinson's Disease Treatments Market Size Market Share by Application in 2021

Figure 23. United States Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Parkinson's Disease Treatments Market Size Market Share by Region in 2021

Figure 28. APAC Parkinson's Disease Treatments Market Size Market Share by Application in 2021

Figure 29. China Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Parkinson's Disease Treatments Market Size Market Share by Country in 2021

Figure 36. Europe Parkinson's Disease Treatments Market Size Market Share by Type in 2021

Figure 37. Europe Parkinson's Disease Treatments Market Size Market Share by Application in 2021

Figure 38. Germany Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Parkinson's Disease Treatments Market Size Market Share by Application in 2021

Figure 46. Egypt Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Parkinson's Disease Treatments Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 52. APAC Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 53. Europe Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 55. United States Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 56. Canada Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 59. China Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 60. Japan Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 61. Korea Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 63. India Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 64. Australia Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 65. Germany Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 66. France Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 67. UK Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 68. Italy Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 69. Russia Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 70. Spain Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 73. Israel Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Parkinson's Disease Treatments Market Size 2023-2028 ($ Millions)